Investors

Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. In 2023 the Company welcomed new investor Oxford Science Enterprises following the successful completion of an additional financing, raising a further $39 million.